3,710,000,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2026-09-30
- Valid until
- still holds
- Published
- 2026-11-04
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "Amgen quarterly operating income: 3,710,000,000 United States dollar", as of 2026-09-30. Claim clm_B7EB0BB6DBEB, https://asof.is/claim/clm_B7EB0BB6DBEB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm.
APA
AsOf. (2026). Amgen quarterly operating income: 3,710,000,000 United States dollar (as of 2026-09-30) [Record clm_B7EB0BB6DBEB]. Retrieved November 9, 2026, from https://asof.is/claim/clm_B7EB0BB6DBEB (source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm)
BibTeX
@misc{asof_clm_B7EB0BB6DBEB,
author = {AsOf},
title = {Amgen quarterly operating income: 3,710,000,000 United States dollar},
year = {2026},
howpublished = {\url{https://asof.is/claim/clm_B7EB0BB6DBEB}},
note = {Claim clm\_B7EB0BB6DBEB, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_B7EB0BB6DBEB.md/v1/claims/clm_B7EB0BB6DBEBsubmit a correction